Objectives-To determine the role of population based indicators of health outcome in local health outcome assessments; the constraints of using such indicators; how they could be made more useful; and whether health authorities had developed their own indicators of health outcome. Design-A structured telephone interview with representatives of 91 of the 100 English health authorities. 
Introduction

POTENTIAL VALUE OF POPULATION BASED INDICATORS OF HEALTH OUTCOME
High quality health care should result in improved health outcome at levels of both the individual patient and the population. Purchasers are concerned about quality at a population level and organisational performance of providers. 1 They could use comparative national indicators of population based health outcome to help assess health outcome. An outlying value of an indicator in a district, compared with the national mean, could stimulate local discussion or formal assessment.
However, population based indicators of health outcome often reflect the underlying level of disease risk in the population. Purchasers can reduce this risk by detecting and managing risk factors in a coordinated way across all levels of health care. For example, there are significant variations in deaths from peptic ulcer between districts 2 but not between hospitals. 3 This suggests that cost eVective methods for risk reduction, early diagnosis, and appropriate drug treatment in primary care may be more useful than improvements in hospital care. For many diseases this increases the purchasers' incentives to design and manage an integrated system of health care with prevention programmes that involve alliances with organisations outside the health sector.
Population based indicators of health outcome can also reflect what happens to minimise the consequences of disease once patients are admitted to hospital-for example, by preventing potentially avoidable complications and premature death. For instance, in one English region mortality 90 days after admission for hip fracture diVered significantly between hospitals. 4 Case mix was unlikely to explain these diVerences as patients admitted to each hospital were similar in age, sex, pre-existing illnesses, and activities of daily living before fracture. Purchasers can use these variations in population based health outcomes within districts to assess the possibility of inappropriate health service delivery or poor access. For example, an investigation into the considerable variations in mortality from coronary heart disease within a district showed that uptake of coronary artery surgery did not correspond with need. 5 In this paper we use the following definition of population health outcome: the attributable eVect of a healthcare intervention on a previous health status at a population level (national, regional, district, locality, or electoral ward).
ventions on health and the extent to which population based indicators of health outcome directly reflect the quality of health care. Yet purchasers have potentially their most direct influence on health care through contracting.
RELEVANCE OF POPULATION BASED INDICATORS
OF HEALTH OUTCOME Guidance to National Health Service (NHS) purchasers has highlighted the need for assessment of health outcomes. 9 10 In England NHS purchasers consist of health authorities, locality commissioning groups, and general practice fundholders (box 1).
The United Kingdom Health of the Nation target areas 10 are national comparative population based indicators of health outcome (box 2). Population health outcome indicators for the NHS is another set of such indicators for the health authorities which was first released as a consultation document 2 and feasibility study 13 in 1993 (box 2 18 These include population based and provider based indicators of health outcome. Its design required information about the ways in which such indicators will be used in practice. The NHS Executive and Department of Health have recognised that they need to consider how measures of health outcome can become central to assessing the performance of health authorities and NHS trusts. 19 A recent survey found that improving clinical eVectiveness was not a priority for many health authorities and most NHS trusts in England and Wales. 20 One conclusion was that their performance needs to be measured with indicators that reflect the eVectiveness of the services they purchase and provide. Health outcomes are now explicitly being considered by the United Kingdom government. 21 The further development of indicators required information on how they are perceived and used by their intended audience. A 1993 study examined assessments of health outcome by district health authority purchasers in England but presented limited information on mortality and morbidity indicators in purchasing health care. 22 Health outcome assessment was in its infancy at that time. Otherwise there have been no relevant surveys. Yet comparative population based indicators of health outcome may have an increasing part to play in assessing the performance of health authorities, and should therefore also be of interest to those who work in health care and who are involved in the management of performance.
This paper presents the results of a survey of English health authorities. The objectives were to determine: the role of population based indicators of health outcome in assessments of local health outcome; the constraints of using such indicators; how they could be made more useful; and whether health authorities had developed their own indicators of health outcome.
There are several varieties of purchasing models in England which are likely to change. This year there are 101 health authorities purchasing hospital and community health services from NHS trusts. (One health authority has been divided into two since our interview). They do this on behalf of all nonfundholding general practitioners (GPs) (about 10 000 GPs are non-fundholders 11 ) and some services on behalf of GP fundholders and commissioning GPs (see below).
GP fundholders purchase some hospital and community health services directly. Many have chosen to act together in consortia, multifunds, or total purchasing projects to purchase a wider range of services (about 15 000 GPs are fundholders 11 ). Purchasing involves other GPs. Commissioning groups led by GPs and others led by health authorities are increasing in numbers. GPs also work in various pilot schemes including practice based contracts with total budgets (about 9000 GPs are commissioning GPs 11 ). Directors of public health are employed by health authorities and lead the public health function in their district. 12 They are executive members of health authority boards. Their responsibilities include assessing local health needs; developing, and as appropriate implementing, local health and health promotion strategies; leading the health authority's work in improving the appropriateness and eVectiveness of clinical and non-clinical interventions; and a key role in developing and sustaining relationships between the health authority and clinicians (including GPs), local authorities, and the local community. They are accountable to their health authority for the surveillance, monitoring, and control of communicable disease and non-communicable environmental exposure. They provide the focus for all local public health advice.
United Kingdom Health of the Nation main target indicators (first published in 1992) 10 CORONARY HEART DISEASE (CHD) AND STROKE 1 To reduce death rates for both CHD and stroke in people <65 by >40% by the year 2000 (baseline 1990). 
Population health outcome indicators for the NHS (developed in 1991 and first published in 1993)
2 13 1 District and regional SMRs for deaths for ages 50-69 caused by breast cancer. 2 Regional SMRs for deaths in people <45 years caused by diabetes. 3 Regional age standardised admission rates for ketoacidosis and coma / 1 000 000 residents per year. 4 Regional age standardised operation rates for lower limb amputations in diabetic patients per 1 000 000 regional residents per year. 5 District and regional SMRs for deaths in people aged 25-74 caused by peptic ulcer. 6 Annual age standardised admission rates for hip fracture per 10 000 district and regional residents >65 years. 7 District and regional SMRs for deaths in people aged 65-84 caused by fracture of proximal femur. 8 District and regional SMRs for deaths in people aged >85 caused by fracture of proximal femur. 9 The total legal abortion rate for all districts and regions. 10 The total legal abortion rate as a percentage of the crude potential fertility rate for all districts and regions. 11 The proportion of terminations of pregnancy that are performed after 12 weeks gestation for all districts and regions. 12 District and regional conception rates for those aged <16/1000 district and regional women residents aged 13-15. 13 Regional rates of infants born with Down's syndrome/100 000 total regional births. 14 Regional proportion of pregnancies with Down's syndrome diagnosed prenatally. 15 Regional rates of infants born with spina bifida / 100 000 total regional births. 16 Regional rates of infants born with anencephaly / 100 000 total regional births. 17 District and regional SMRs for all deaths due to skull fracture and intracranial injury. 18 Regional SMRs for deaths in children aged <15 years due to skull fracture and intracranial injury. 19 Regional SMRs for deaths between the ages of 15 and 24 years due to skull fracture and intracranial injury. 20 The district and regional age standardised rate of notifications of pertussis in children aged <15 years. 21 The district and regional age standardised rate of notifications of measles in children under the age of 15 years. 22 The district and regional proportion of children reaching their 1st birthday who are immunised against pertussis. 23 The district and regional proportion of children reaching their 2nd birthday who are immunised against measles. 24 District and regional male birth cohort specific orchidopexy rate by the 5th birthday. 25 Annual district and regional orchidopexy rate in boys aged 5 to 14 years. 26 Annual district and regional proportion of boys undergoing orchidopexy who are over the age of 5 years. 27 Regional age standardised rate of renal replacement therapy/1 000 000 residents/ year. 28 District and regional SMRs for all deaths with the underlying cause as suicide and self inflicted injury combined with deaths from injuries undetermined, whether accidental or purposely inflicted. 29 District and regional SMRs for deaths in people aged 15-44 years with the underlying cause as suicide and self inflicted injury combined with deaths from injuries undetermined, whether accidental or purposely inflicted. 30 Regional SMRs for deaths mentioned as associated with schizophrenic psychoses in people aged <75 years. * Many of these indicators are population based process indicators used as proxies for improved health outcome.
Box 2 Some of the national comparative health outcome indicators based on populations published annually in England*
Methods After a series of face to face interviews we developed and piloted the questionnaire. Pilot interviews told us that local directors of public health received four to five postal questionnaires each week from a variety of research groups. We therefore used a telephone interview to ensure a higher response rate than we would have obtained from a postal questionnaire. A steering group advised on and approved the development of the questionnaire. We sent the questionnaire to directors of public health in all 100 English health authorities (box 1) and asked to arrange a semistructured telephone interview with them or a nominated colleague. We sent a further copy of the questionnaire before the interview.
The interview covered the following grounds:
x ROLE OF POPULATION BASED INDICATORS OF HEALTH OUTCOME IN ASSESSMENTS OF LOCAL HEALTH OUTCOME
We asked for two local examples of clinical areas in which population health outcome assessments had been of most value. For each of these areas we asked why they had chosen the area, further information that had been required, whether they had examined data validity, the changes to services that they had made, and what were the resource implications for future services.
x CONSTRAINTS IN THE USE OF POPULATION BASED INDICATORS OF HEALTH OUTCOME
We asked them to list the main constraints in the use of such indicators.
x HOW POPULATION BASED INDICATORS OF HEALTH OUTCOME COULD BE MADE MORE
USEFUL
We asked how population based indicators of health outcome could be made more useful.
x HEALTH AUTHORITIES DEVELOPING THEIR OWN
INDICATORS
We found when we were piloting our questionnaire that health authorities had developed their own indicators of health outcome. Many of these indicators could be used at a provider or population level especially in those health authorities where there was only one local provider. Although the main focus of this study was on population based indicators we thought that it was important to record the local use of all indicators of health outcome as this could have implications for the further development of national population based indicators of health outcome. If health authorities had developed their own indicators we asked whether they were using them to manage the performance of local providers.
SUBJECTS
We interviewed representatives of 91 of the 100 health authorities between October and December 1995. Of those interviewed 68% (61) were directors of public health, 26% (21) were consultants in public health medicine, and two were non-clinical epidemiologists, two were research managers, and one was a resource centre manager. We conducted this study at a time of major change in the NHS and only half of those interviewed had been in post for more than two years.
ANALYSIS OF DATA
All the interviews were conducted by AMc with GF listening in to each interview and writing the responses. Immediately after each interview we agreed on the appropriate coding for each response before the data were entered into the database. The interviews were not recorded on tape. We ensured the reliability of the analyses to identify similar phrases, pattern themes, and diVerences in health authority responses by both AMc and GF independently analysing the data and drawing their own conclusions for each section of the questionnaire. The coding sheets, data base, and anonymised transcripts from each interview are available.
Results
ROLE OF POPULATION BASED INDICATORS OF HEALTH OUTCOME IN ASSESSMENTS OF LOCAL
HEALTH OUTCOME Box 3 summarises the key results from this study. We published the full results of the questionnaire in October 1996. 23 We obtained details on 147 examples in over 30 clinical areas (table 1) . Of these examples 60% were in Health of the Nation areas. Table 2 lists the most common reasons for choosing the examples. Health authorities investigated 50 of the 147 examples (34%) because indicators with national data suggested an outlying value. Of these, 32 were Health of the Nation indicators (box 2), nine were from Population indicators of health outcome for the NHS (box 2). Seven were indicators from the public health common data set, and two were derived from general practitioner prescribing data (prescription analysis and cost-PACT data). The health authorities investigated 20 of the examples (14%) because they had found variations in population based indicators of health outcome in subdistricts (localities or electoral wards) for rates of termination of pregnancy (seven), mortality from coronary heart disease (five), breast cancer (four), fractured neck of femur (one), orchidopexy (one), perinatal mortality (one), and lung cancer (one).
They had obtained further information with various methods including service reviews, needs assessment projects, case control studies, small area variations analyses, action research, and the use of focus groups. Interviewees had examined the validity of data in at least 61 (41%) of the examples. They had made a wide range of changes to services including the development of local guidelines, the appointment of new personnel, the increased uptake of eVective interventions, and improved targeting of preventive measures.
They had set up monitoring arrangements in most of the 147 examples, roughly half were compared with national indicators to monitor changes and the rest with locally collected data.
None of the 147 examples saved costs of service delivery. There were at least 28 districts in which assessments of population health outcome had clearly identified unmet need, 10 of which had outlying indicator values. All of these assessments would have resulted in considerable increased investment.
CONSTRAINTS IN THE USE OF POPULATION BASED
INDICATORS OF HEALTH OUTCOME Table 3 contains the constraints identified. The health authorities had examined the validity of data in at least 61 of the 147 examples (41%). This was more likely to happen if they used national comparative data and in certain clinical areas. For instance, all eight health authorities investigating suicide validated national data with local studies or confidential enquiries with coroner reports or death notifications. Routine data can both underestimate and overestimate a clinical problem and there were examples of both.
HOW POPULATION INDICATORS OF HEALTH OUTCOME COULD BE MADE MORE USEFUL
Twenty three interviewees (25%) spontaneously advocated the increased use of process indicators as proxies for health outcome. They used evidence based drug treatments as process indicators to monitor the delivery of health care. Twenty one interviewees mentioned the rates of use of thrombolytic agents after myocardial infarction, five the administration of steroids for preterm deliveries, and seven the use of PACT data-for example, the ratio of inhaled steroids to inhaled bronchodilators in the treatment of asthma.
Sixteen interviewees (18%) expressed the need for or mentioned the usefulness of trends in indicators. Ten interviewees (11%) found it more useful to compare their district's indicator values with other districts with a similar population structure, or with neighbouring districts, than to compare their indicator values nationally. Other areas in which interviewees said they wanted to use population indicators of health outcome were mental health, cancer services, coronary heart disease, primary care, stroke, diabetes, child health, and renal disease. Lack of routine data, resources, and time within their departments were the main reasons preventing them.
HEALTH AUTHORITIES DEVELOPING THEIR OWN
INDICATORS
Twenty seven authorities (30%) had developed their own provider based indicators of health outcome and of these 10 were using them to manage the performance of local providers. Clinical audit was an important means of The following were chosen on one occasion: maternity care, low birthweight babies, vascular surgery, varicose veins, tuberculosis, tobacco smoking in young people, lung cancer, colorectal cancer, back pain, AIDS care, cataract surgery, orthopaedic services, and accidents.
Table 2 Most common reasons why clinical areas had been chosen Reasons for the choice Clinical areas (n)
Indicators using national data suggested that their district had an outlying value*
50
Clinical area was a Health of the Nation area (but district did not have an outlying indicator value)
27
Analysis suggested variation within the district in a health outcome based on a population
20
Reacting to local concerns (including clinician concerns) 18 The health authority had decided that the area was an important local issue or condition
14
Variations within the district in access for particular groups of people 9 The high costs of a particular service 8 *An outlying value meant that the value of an indicator for that district was high compared with the national mean. We did not measure these indicator values. Some respondents gave more than one reason and this table lists those which were the most common.
Health authorities used national comparative health outcome indicators based on populations to stimulate assessment of local health outcomes largely in Health of the Nation areas with outlying values.
The main perceived constraints in the use of health outcome indicators based on populations were: data validity and timeliness and the relevance of health outcomes to the quality of health care. The diYculties of changing clinical behaviour, and organisational change within health authorities also limited their usefulness.
The NHS could make population based health outcome indicators more useful if they were used in conjunction with evidence based process indicators.
Nearly a third of health authorities in this survey had developed their own indicators, mostly process indicators, and 10 were using their own indicators to manage the performance of local provider units.
Some of the indicators developed by health authorities may not be comparable between districts, as definitions of numerator and denominator data sometimes diVer. We should encourage the standardisation of definitions used in such indicators.
Box 3 The key points from this study.
developing these local indicators. Examples included complication rates and functional quality of life measures for hip replacement; outcome indicators in contracts for subfertility treatment; and outcome indicators for cataract surgery. Health authorities and hospitals could produce numerator and denominator data for many of these indicators more quickly than any comparative national package of indicators. Another 12 districts were at varying stages of developing their own indicators for possible use in managing local providers. Five districts described the development of their own indicators that were not focused on providers. These included supplementary Health of the Nation indicators, general practitioner prescribing indicators, healthy alliance indicators, and locality profiles containing indicators.
Discussion
ROLE OF POPULATION BASED INDICATORS OF
HEALTH OUTCOME IN LOCAL HEALTH OUTCOME
ASSESSMENTS
The study showed that indicators of health outcome based on the population within a health authority had a significant role in prompting districts to undertake assessments of health outcome within their population. Health authorities also used these indicators to examine local variations in health outcome and the indicators helped to highlight areas for further investigation, initiated data validation, and enabled the monitoring of changes to services. To some extent we validated the responses. We asked for health authority documents to support their examples and subsequently commissioned over 30 case studies from 18 health authorities. Over a third of these case studies focus on the use of national indicators. 23a Our study had a high response rate (91%) and consistency in interviewing. We asked for two local examples of clinical areas in which assessments of population based health outcomes had been of most value. We did not ask respondents to identify the use of all population based indicators of health outcome within their authorities.
CONSTRAINTS IN THE USE OF POPULATION BASED INDICATORS OF HEALTH OUTCOME
The validity and timeliness of data may improve if more health authorities and trusts use national indicators and re-examine their local data. The usefulness of such indicators is limited by the diYculty of changing clinical and organisational behaviour as are other aspects of health authority work especially at a time of organisational turbulence. In the United Kingdom part of the national research and development programme is to consider how best to implement research findings in practice. Research is also needed into the attributability of indicators to the quality of health care.
Despite such constraints in the use of population based indicators of health outcome they do have advantages over provider based indicators. The larger numbers mean that variation is less likely to be due to chance. Population based health outcomes also give a global assessment of outcome that incorporates those people not treated by providers. Variation between districts may still be due to differences in incidence of disease or to variation in data collection but such problems are more likely at a provider level. Many of the constraints such as data validity and relevance also apply to provider based health outcomes. 24 It was perhaps surprising that we identified these constraints in so few interviewees. Further training may be required for those who use and interpret such indicators. 25 
HOW POPULATION INDICATORS OF HEALTH OUTCOME COULD BE MADE MORE USEFUL
Interviewees suggested that population indicators of health outcome could be made more useful if they were used in conjunction with evidence based process indicators. Such process indicators are more readily available than indicators of health outcome, can be used at a subdistrict level or in contracting and audit, and can overcome or sidestep many of the problems that beset health outcome data such as attributability and interpretation. 26 27 They may be more meaningful to clinicians at a provider level than district based indicators of health outcome. They therefore may help to ensure that clinicians use the interventions in the correct way and on the appropriate people. The public health common data set user consultation document 28 contained proposals for bringing process and outcome indicators together within a structural framework and a template for standardised specification of all indicators produced by the Department of Health's Central Health Outcomes Unit. Many of the indicators advocated as indicators of health outcome-such as those in box 2-are process indicators that are proxies for improved health outcome.
The public health common data set now presents trend data for many indicators. However, these may not be reliable as they have been analysed for the most recent health area boundaries and there have been changes in data coding systems at the former OYce of Population and Surveys. 23 Comparisons between districts with similar socioeconomic composition or with neighbouring districts are more likely to be useful than an overall league table, which could encourage complacency in districts that, although they are not outliers, are performing poorly relative to their socioeconomic profile. (The public health common data set now uses the classification system of the OYce for National Statistics, which presents similar districts and grouped values.
16 ) The programme in England to identify and develop sets of outcome indicators, already mentioned, 18 will cover most of the areas highlighted by interviewees as topics in which they wanted to use indicators. At present the valid and timely indicators that can be used are limited by reliance on routine mortality and hospital data. The programme will make suggestions for new methods of data collection.
HEALTH AUTHORITIES DEVELOPING THEIR OWN
INDICATORS
In our survey at least a third of districts were developing their own indicators which can be relatively quick and easy to develop. Health authorities can produce their own indicators with data from local contracting and clinical audit, and now have considerable influence in funding and determining audit projects for providers. We would need further study to determine the extent to which these indicators were linked to a system of penalties or incentives and what was meant by the management of performance of local providers.
Some of the indicators developed by health authorities may not be comparable between districts, as definitions of numerator and denominator data sometimes diVer. For example, we detected diVerences between districts in how they defined data for "door to needle time" for thrombolytic therapy after myocardial infarction, and mortality after hip fracture. The Department of Health and NHS Executive have a role in encouraging the standardisation of the definitions used in such indicators.
Conclusions
In this study we found that in health authorities population based indicators of health outcome had a significant role in prompting districts to undertake assessments of health outcome within their population. There were constraints on the use of such indicators and recommendations were made as to how they could be made more useful. A third of health authorities had developed their own indicators. The findings have and will influence the development of national comparative population based indicators of health outcome. Such indicators may have an increasing part to play in assessing the performance of English health authorities and NHS trusts (table 4) .
